R/R CD19-POSITIVE B-CELL MALIGNANCIES

Clinical trials for R/R CD19-POSITIVE B-CELL MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new R/R CD19-POSITIVE B-CELL MALIGNANCIES trials appear

Sign up with your email to follow new studies for R/R CD19-POSITIVE B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New cell therapy tested for tough blood cancers

Disease control Terminated

This early-stage study tested a new cell therapy called CNTY-101 in 28 patients with relapsed or hard-to-treat B-cell blood cancers. The main goals were to find a safe dose and see how the body processes the treatment. The study was terminated early, and it focused on patients wh…

Matched conditions: R/R CD19-POSITIVE B-CELL MALIGNANCIES

Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

R/R CD19-POSITIVE B-CELL MALIGNANCIES

Get alerted when new R/R CD19-POSITIVE B-CELL MALIGNANCIES trials appear

New cell therapy tested for tough blood cancers